We are live on ! Find out more
CJL

Cyrus J. Lawrence Portfolio holdings

AUM $26.4M
1-Year Est. Return 16.63%
This Fund
S&P 500
This Quarter Est. Return
-2.49%
1 Year Est. Return
+16.63%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$365M
AUM Growth
+$364M
Cap. Flow
+$21.3M
Cap. Flow %
5.84%
Top 10 Hldgs %
39.32%
Holding
152
New
4
Increased
27
Reduced
26
Closed
24

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$9.65M
2
META icon
Meta Platforms (Facebook)
META
+$8.13M
3
ORCL icon
Oracle
ORCL
+$6.47M
4
BLK icon
Blackrock
BLK
+$6.1M
5
NVO
Novo Nordisk
NVO
+$5.43M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$7.49M
2
CB icon
Chubb
CB
+$6.73M
3
F icon
Ford
F
+$2M
4
ASML icon
ASML
ASML
+$199K
5
COST icon
Costco
COST
+$182K

Sector Composition

Rank Sector Weight
1 Technology 29.23%
2 Healthcare 19.04%
3 Financials 12.04%
4 Communication Services 9.56%
5 Consumer Discretionary 9.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADP icon
126
Automatic Data Processing
ADP
$106B
-55
Closed -$12
AES icon
127
AES
AES
$10.5B
-68
Closed -$14
ALGT icon
128
Allegiant Air
ALGT
$2.86B
-200
Closed -$25
BMO icon
129
Bank of Montreal
BMO
$127B
-1,400
Closed -$126
CSL icon
130
Carlisle Companies
CSL
$14.8B
-70
Closed -$17
D icon
131
Dominion Energy
D
$60.2B
-200
Closed -$10
DHR icon
132
Danaher
DHR
$136B
-226
Closed -$48
DVY icon
133
iShares Select Dividend ETF
DVY
$23.6B
-623
Closed -$70
HIG icon
134
Hartford Financial Services
HIG
$38.9B
-150
Closed -$10
ILMN icon
135
Illumina
ILMN
$29.9B
-72
Closed -$13
MET icon
136
MetLife
MET
$61.3B
-81
Closed -$45
OEF icon
137
iShares S&P 100 ETF
OEF
$20.4B
-300
Closed -$62
RTX icon
138
RTX Corp
RTX
$292B
-58,803
Closed -$5.76K
UL icon
139
Unilever
UL
$137B
-187
Closed -$10
WOOF icon
140
Petco
WOOF
$828M
-1,440
Closed -$12

Similar funds

Cyrus J. Lawrence's Q3 2023 Portfolio in Review

As of Q3 2023, Cyrus J. Lawrence held 152 positions worth $365M, up 78,774% from $462K the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Cyrus J. Lawrence deployed $21.3M of net new capital in Q3 2023, opening 4 new positions and adding to 27 existing holdings. Its largest new stake was Merck: 89,544 shares worth $9.22M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $7.49M trimmed.

  • Cyrus J. Lawrence's largest Q3 2023 buy was Merck: 89,544 shares worth $9.22M.
  • Cyrus J. Lawrence added most to Meta Platforms (Facebook) in Q3 2023, an estimated $8.13M increase.
  • Cyrus J. Lawrence's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $7.49M.
  • Cyrus J. Lawrence fully exited RTX Corp in Q3 2023, selling an estimated $5.76K.
  • Cyrus J. Lawrence's ten largest holdings make up 39% of its $365M portfolio in Q3 2023.
  • Cyrus J. Lawrence opened 4 new positions and closed 24 in Q3 2023.
  • Cyrus J. Lawrence's portfolio value rose 78,774% quarter-over-quarter to $365M.

Based on Cyrus J. Lawrence's 13F filing for Q3 2023, filed 9 Nov 2023.